Diego Correa
Impact in
- Genetics top 0.5%
- Mesenchymal stem cell research
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms
Papers in
- Genetics 29
- Mesenchymal stem cell research 29
- Rheumatology 14
- Osteoarthritis Treatment and Mechanisms 14
- Co-authors
- Arnold I. Caplan (10 shared papers)Dimitrios Kouroupis (21 shared papers)Rodrigo A. Somoza (5 shared papers)Lee D. Kaplan (12 shared papers)Thomas Michael Best (11 shared papers)Jean F. Welter (2 shared papers)Steven A. Lietman (1 shared paper)Paul Y. Lin (5 shared papers)
- Journals
- Frontiers in Bioengineering and Biotechnology (5 papers)Cytotherapy (5 papers)Stem Cells Translational Medicine (4 papers)Nature Reviews Drug Discovery (3 papers)Stem Cell Research (2 papers)
- Partner nations
- United StatesItalyNicaragua
In The Last Decade
Diego Correa
57 papers receiving 4.4k citations
Diego Correa's Hit Papers
Peers
Comparison fields: 5 of 104
- Genetics 1.8k
- Rheumatology 840
- Urology 170
- Rehabilitation 139
- Biomedical Engineering 664
Countries citing papers authored by Diego Correa
This map shows the geographic impact of Diego Correa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Correa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Correa more than expected).
Fields of papers citing papers by Diego Correa
This network shows the impact of papers produced by Diego Correa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Correa. The network helps show where Diego Correa may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Correa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The MSC: An Injury Drugstore Hit paper breakdown → | 2011 | 1373 |
| 2 | 2018 | 327 | |
| 3 | Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial Hit paper breakdown → | 2021 | 314 |
| 4 | Chondrogenic Differentiation of Mesenchymal Stem Cells: Challenges and Unfulfilled Expectations Hit paper breakdown → | 2014 | 296 |
| 5 | 2011 | 264 | |
| 6 | 2016 | 143 | |
| 7 | 2014 | 109 | |
| 8 | 2021 | 106 | |
| 9 | 2010 | 89 | |
| 10 | 2010 | 86 | |
| 11 | 2020 | 80 | |
| 12 | 2022 | 79 | |
| 13 | 2020 | 78 | |
| 14 | 2018 | 76 | |
| 15 | 2012 | 69 | |
| 16 | 2008 | 67 | |
| 17 | 2019 | 63 | |
| 18 | 2015 | 60 | |
| 19 | 2021 | 59 | |
| 20 | 2011 | 54 |
About Diego Correa
Diego Correa is a scholar working on Genetics, Rheumatology, Oncology, Orthopedics and Sports Medicine and Molecular Biology, having authored 59 papers that have together received 4.5k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (29 papers), Osteoarthritis Treatment and Mechanisms (14 papers), Bone Metabolism and Diseases (7 papers), Tissue Engineering and Regenerative Medicine (4 papers), Cancer Cells and Metastasis (3 papers), Bone Tissue Engineering Materials (3 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Genetics (1.8k citations), Rheumatology (840 citations), Urology (170 citations), Rehabilitation (139 citations) and Biomedical Engineering (664 citations). Diego Correa has collaborated with scholars based in United States, Italy and Nicaragua. Frequent co-authors include Arnold I. Caplan, Dimitrios Kouroupis, Rodrigo A. Somoza, Lee D. Kaplan, Thomas Michael Best, Jean F. Welter, Steven A. Lietman, Paul Y. Lin, Jose Perez and Deborah J. Li. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, Cytotherapy, Stem Cells Translational Medicine, Nature Reviews Drug Discovery and Stem Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.